Company: HURA
Filing Date: 2025-09-18
Form Type: S-1/A
Source: 0001193125-25-207395
Chunk: 242

Company: TuHURA Biosciences, Inc./NV
Filing Date: 2025-09-18
Form: S-1/A
Chunk 242
---
 the completeness and accuracy of the underlying data used in the estimates and evaluating the significant assumptions including, but not limited, to obtaining an understanding of the Company’s estimation process, corroborating the progress of clinical trials with the Company’s clinical teams, obtaining confirmations directly from third parties and obtaining third party invoices related to the performance of the services provided. We also tested a sample of subsequent payments to assess the reasonableness of the Company’s accruals.

/s/ Marcum LLP

Marcum LLP

We have served as the Company’s auditor since 2019.

San Francisco, CA

October 7, 2024**

<div align='center'>F-4</div>

Kintara Therapeutics, Inc. Consolidated Balance Sheets (In thousands, except par value amounts)

|                                                                                    |     |      |     |     | June 30,2024 |          |   |     | June 30,2023 |          |   |
|:-----------------------------------------------------------------------------------|:----|:-----|----:|:----|:-------------|---------:|:--|:----|:-------------|---------:|:--|
|                                                                                    |     | Note |     |     | $            |          |   |     | $            |          |   |
| Assets                                                                             |     |      |     |     |              |          |   |     |              |          |   |
| Current assets                                                                     |     |      |     |     |              |          |   |     |              |          |   |
| Cash and cash equivalents                                                          |     |      |     |     |              |    4,909 |   |     |              |    1,535 |   |
| Prepaid expenses, deposits and other                                               |     |      |     |     |              |      414 |   |     |              |      660 |   |
| Clinical trial deposit                                                             |     |      |   3 |     |              |      205 |   |     |              |    1,075 |   |
| Total current assets                                                               |     |      |     |     |              |    5,528 |   |     |              |    3,270 |   |
| Property and equipment, net                                                        |     |      |   5 |     |              |      674 |   |     |              |      709 |   |
| Total assets                                                                       |     |      |     |     |              |    6,